Skip to content
  • About
    • Staff
    • Close collaborators
  • Trials
    • Ongoing Trials
    • Planned Trials
    • Completed Trials
    • Collaborative Investigator trials and cohorts
    • All Trials
  • VAXXAIR
    • Recruitment to Vaxxair
  • CURE
    • Cluster A
    • Cluster B
    • Cluster C
    • Cluster D
    • Cluster E
    • Cluster F
  • MineraloCAP & MineraloCOP
    • Patient Information
      • MineraloCAP
      • MineraloCOP
    • Protocol
      • MineraloCAP
      • MineraloCOP
  • HEAT-LUNG
  • Climate
  • About
    • Staff
    • Close collaborators
  • Trials
    • Ongoing Trials
    • Planned Trials
    • Completed Trials
    • Collaborative Investigator trials and cohorts
    • All Trials
  • VAXXAIR
    • Recruitment to Vaxxair
  • CURE
    • Cluster A
    • Cluster B
    • Cluster C
    • Cluster D
    • Cluster E
    • Cluster F
  • MineraloCAP & MineraloCOP
    • Patient Information
      • MineraloCAP
      • MineraloCOP
    • Protocol
      • MineraloCAP
      • MineraloCOP
  • HEAT-LUNG
  • Climate
Contact

Cluster E

Acute and persisting lung infections.

  • Influence of Pseudomonas aeruginosa on the prognosis of Chronic Obstructive Pulmonary Disease (COPD)
  • Prophylactic properties of hydroxychloroquine 
  • Risk of pneumonia hospitalization in the Danish population and COPD outpatients.
  • The effect of social distancing on the risk of hospitalization caused by pneumonia of patients who have been diagnosed with bronchiectasis
  • Is SARS-CoV-2 infection and post-acute sequelae associated with suicide, admission to psychiatric hospital and higher use of psychoactive medication?
  • The impact of social distancing due to COVID-19 on admissions and mortality rates in patients with obstructive lung disease
  • Infection with Streptococcus Pneumonia in patients with COPD and the incidence of MACE within the first 14 days following the infection – a multiregional epidemiological study
  • Risk of infection with Staphylococcus aureus with use of inhaled corticosteroids in patients with non-cystic fibrosis bronchiectasis
  • Inhaled corticosteroids in patients with chronic obsructive lung disease. Assessing the risk of Non-Tuberculous Mycobacteria Infection

 

 

  • Research Director
  • Jens Ulrik Jensen
  • Administrative leaders
  • Pradeesh Sivapalan
  • Josefin Eklöf
  • Dorthe Høgsberg
  • Contact information:
  • Send mail
  • 38673413
  • Social media:
  • linkedin
Copenhagen Respiratory Research | 2025

Privatspolitik

  • Design og udvikling af Lægeweb